SL

Stephen Li

Senior Vice President, Regulatory Affairs at Karyopharm Therapeutics

Stephen Li is an accomplished professional in the field of Regulatory Affairs with extensive experience in academia and industry. Currently serving as a Lecturer in the Graduate Program at Northeastern University since September 2021, Stephen develops and lectures graduate-level courses focused on global Regulatory Affairs. Concurrently, since September 2020, Stephen holds the position of Senior Vice President for Regulatory Affairs at Karyopharm Therapeutics Inc., following a prior role as Vice President. Stephen's prior experience includes significant positions at Merck Group from August 2005 to September 2020, where responsibilities spanned U.S. Head of Global Regulatory and Scientific Policy and Global Head of Regulatory Affairs for marketed products. Stephen also held teaching roles, including a professorship at Humber College from 2007 to April 2013, and has a strong educational background with degrees from institutions such as the University of Toronto and Ivey Business School at Western University, including an Executive MBA.

Location

Boston, United States

Links

Previous companies


Org chart


Teams


Offices


Karyopharm Therapeutics

13 followers

Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an innovation-driven pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm's Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1).


Industries

Employees

201-500

Links